Tacrolimus induces glomerular injury via endothelial dysfunction caused by reactive oxygen species and inflammatory change

Kidney and Blood Pressure Research

Volumn 35, Issue 6, 2013, Pages 549-557

  Kidokoro, Kengo ^a   Satoh, Minoru ^a   Nagasu, Hajime ^a   Sakuta, Takeo ^a   Kuwabara, Atsunori ^a   Yorimitsu, Daisuke ^a   Nishi, Yuko ^a   Tomita, Naruya ^a   Sasaki, Tamaki ^a   Kashihara, Naoki ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensin II receptor blocker; NAD(P)H oxidase; Nephrotoxicity; Oxidative stress; Tacrolimus

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TACROLIMUS; TELMISARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY INJURY; MACROPHAGE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WISTAR RAT;

ANIMALS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; KIDNEY GLOMERULUS; MALE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; TACROLIMUS;

EID: 84864818928     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000339494     Document Type: Article

References (33)

1. Halloran PF: Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 2715-2729.
2. Henry ML: Cyclosporine and tacrolimus (FK506): A comparison of efficacy and safety profiles. Clin Transplant 1999; 13: 209-220.
3. Tocci MJ, Matkovich DA, Collier KA, Kwok P, Dumont F, Lin S, Degudicibus S, Siekierka JJ, Chin J, Hutchinson NI: The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 1989; 143: 718-726.
4. Dieperink H, Starklint H, Leyssac PP, Kemp E: Glomerulotubular function in cyclosporine-treated rats. A lithium clearance, occlusion time/transit time and micropuncture study. Proc Eur Dial Transplant Assoc Eur Ren Assoc 1985; 21: 853-859.
5. Williams D, Haragsim L: Calcineurin nephrotoxicity. Adv Chronic Kidney Dis 2006; 13: 47-55.
6. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M: Cyclosporine- associated chronic nephropathy. N Engl J Med 1984; 311: 699-705.
7. Kurtz A, Della Bruna R, Kuhn K: Cyclosporine A enhances renin secretion and production in isolated juxtaglomerular cells. Kidney Int 1988; 33: 947-953.
8. Hocherl K, Dreher F, Vitzthum H, Kohler J, Kurtz A: Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney. J Am Soc Nephrol 2002; 13: 2427-2436.
9. Cook LG, Chiasson VL, Long C, Wu GY, Mitchell BM: Tacrolimus reduces nitric oxide synthase function by binding to FKBP rather than by its calcineurin effect. Kidney Int 2009; 75: 719-726.
10. Zhong Z, Arteel GE, Connor HD, Yin M, Frankenberg MV, Stachlewitz RF, Raleigh JA, Mason RP, Thurman RG: Cyclosporin A increases hypoxia and free radical production in rat kidneys: Prevention by dietary glycine. Am J Physiol 1998; 275:F595-F604.
11. Diederich D, Skopec J, Diederich A, Dai FX: Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension 1994; 23: 957-961.
12. Satoh M, Fujimoto S, Haruna Y, Arakawa S, Horike H, Komai N, Sasaki T, Tsujioka K, Makino H, Kashihara N: NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 2005; 288:F1144-F1152.
13. Fujimoto S, Satoh M, Horike H, Hatta H, Haruna Y, Kobayashi S, Namikoshi T, Arakawa S, Tomita N, Kashihara N: Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production. Hypertens Res 2008; 31: 305-313.
14. Vetter M, Chen ZJ, Chang GD, Che D, Liu S, Chang CH: Cyclosporin A disrupts bradykinin signaling through superoxide. Hypertension 2003; 41: 1136-1142.
15. Han SY, Mun KC, Choi HJ, Kwak CS, Bae JH, Suh SI, Park SB, Kim HC, Chang EJ: Effects of cyclosporine and tacrolimus on the oxidative stress in cultured mesangial cells. Transplant Proc 2006; 38: 2240-2241.
16. Kuwabara A, Satoh M, Tomita N, Sasaki T, Kashihara N: Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia 2010; 53: 2056-2065.
17. Nagasu H, Satoh M, Kuwabara A, Yorimitsu D, Sakuta T, Tomita N, Kashihara N: Renal denervation reduces glomerular injury by suppressing nad(p)h oxidase activity in Dahl salt-sensitive rats. Nephrol Dial Transplant 2010; 25: 2889-2898.
18. Nagasu H, Satoh M, Yorimitsu D, Tomita N, Sasaki T, Kashihara N: Comparison of combination therapy of olmesartan plus azelnidipine or hydrochlorothiazide on renal and vascular damage in SHR/NDmcr-cp rats. Kidney Blood Press Res 2011; 34: 87-96.
19. Nagasu H, Satoh M, Kuwabara A, Yorimitsu D, Kidokoro K, Nishi Y, Tomita N, Sasaki T, Kashihara N: Overexpression of klotho protein modulates uninephrectomy-induced compensatory renal hypertrophy by suppressing IGF-I signals. Biochem Biophys Res Commun 2011; 407: 39-43.
20. Satoh M, Ogita H, Takeshita K, Mukai Y, Kwiatkowski DJ, Liao JK: Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci USA 2006; 103: 7432-7437.
21. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS: Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. Kidney Int 2002; 61: 186-194.
22. Khanna AK, Pieper GM: NADPH oxidase subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model. Nephrol Dial Transplant 2007; 22: 376-385.
23. Zhou X, Yang G, Davis CA, Doi SQ, Hirszel P, Wingo CS, Agarwal A: Hydrogen peroxide mediates FK506-induced cytotoxicity in renal cells. Kidney Int 2004; 65: 139-147.
24. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM: Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002; 105: 1656-1662.
25. Timerman AP, Ogunbumni E, Freund E, Wiederrecht G, Marks AR, Fleischer S: The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. Dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. J Biol Chem 1993; 268: 22992-22999.
26. Cameron AM, Steiner JP, Roskams AJ, Ali SM, Ronnett GV, Snyder SH: Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates CA 2+ flux. Cell 1995; 83: 463-472.
27. Cameron AM, Steiner JP, Sabatini DM, Kaplin AI, Walensky LD, Snyder SH: Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc Natl Acad Sci USA 1995; 92: 1784-1788.
28. Papaccio G, Latronico MV, Graziano A, Lanza A, Pedulla M: Tacrolimus, but not cyclosporine a, significantly increases expression of ICAM-1 and IFN-gamma in the nod mouse. J Cell Biochem Suppl 2001;(suppl 36):107-116.
29. Qin P, Tang X, Elloso MM, Harnish DC: Bile acids induce adhesion molecule expression in endothelial cells through activation of reactive oxygen species, NF-kappaB, and p38. Am J Physiol Heart Circ Physiol 2006; 291:H741-H747.
30. Kim SR, Bae YH, Bae SK, Choi KS, Yoon KH, Koo TH, Jang HO, Yun I, Kim KW, Kwon YG, Yoo MA, Bae MK: Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim Biophys Acta 2008; 1783: 886-895.
31. Toba H, Miki S, Shimizu T, Yoshimura A, Inoue R, Sawai N, Tsukamoto R, Murakami M, Morita Y, Nakayama Y, Kobara M, Nakata T: The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta. Eur J Pharmacol 2006; 549: 124-132.
32. Namikoshi T, Satoh M, Tomita N, Haruna Y, Kobayashi S, Komai N, Sasaki T, Kashihara N: Pioglitazone ameliorates endothelial dysfunction in obese rats with nephropathy. Biochem Biophys Res Commun 2007; 361: 835-840.
33. Takeda K, Ichiki T, Tokunou T, Funakoshi Y, Iino N, Hirano K, Kanaide H, Takeshita A: Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells. Circulation 2000; 102: 1834-1839.